TEVA PHARMACEUTICAL INDUSTRIES LIMITED Fair Value, Assets Measured on Recurring Basis, Gain (Loss) Included in Other Income (Deprecated 2013-01-31)
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) reported Fair Value, Assets Measured on Recurring Basis, Gain (Loss) Included in Other Income (Deprecated 2013-01-31) of $1.00 million for the 12-month period ending 2013-12-31, per its 6-K filed 2014-05-02.
Discontinued › Income Statement › Other Income
us-gaap:FairValueAssetsMeasuredOnRecurringBasisGainLossIncludedInOtherIncome · last filed 2014-05-02
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED fair value, assets measured on recurring basis, gain (loss) included in other income (deprecated 2013-01-31) for the quarter ending 2013-12-31 was $0.00, a 100.00% decline year-over-year.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED fair value, assets measured on recurring basis, gain (loss) included in other income (deprecated 2013-01-31) for the quarter ending 2013-09-30 was $0.00.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED fair value, assets measured on recurring basis, gain (loss) included in other income (deprecated 2013-01-31) for the quarter ending 2013-06-30 was $0.00.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED fair value, assets measured on recurring basis, gain (loss) included in other income (deprecated 2013-01-31) for the quarter ending 2013-03-31 was $1.00M, a 75.00% decline year-over-year.
| Period end | Fair Value, Assets Measured on Recurring Basis, Gain (Loss) Included in Other Income (Deprecated 2013-01-31) 0 month | Fair Value, Assets Measured on Recurring Basis, Gain (Loss) Included in Other Income (Deprecated 2013-01-31) 3 month | Fair Value, Assets Measured on Recurring Basis, Gain (Loss) Included in Other Income (Deprecated 2013-01-31) 6 month | Fair Value, Assets Measured on Recurring Basis, Gain (Loss) Included in Other Income (Deprecated 2013-01-31) 9 month | Fair Value, Assets Measured on Recurring Basis, Gain (Loss) Included in Other Income (Deprecated 2013-01-31) 12 month |
|---|---|---|---|---|---|
| 2013-12-31 | $1.00M 20-F · filed 2014-02-10 | $0.00 derived: 6-K 12 month − 6-K 9 month · filed 2014-05-02 | $0.00 derived: sum of 2 quarters · filed 2014-05-02 | $0.00 derived: sum of 3 quarters · filed 2014-05-02 | $1.00M 6-K · filed 2014-05-02 |
| 2013-09-30 | $0.00 derived: 6-K 9 month − 6-K 6 month · filed 2013-10-31 | $0.00 derived: sum of 2 quarters · filed 2013-10-31 | $1.00M 6-K · filed 2013-10-31 | $2.00M derived: sum of 4 quarters · filed 2013-10-31 | |
| 2013-06-30 | $0.00 derived: 6-K 6 month − 6-K 3 month · filed 2013-08-01 | $1.00M 6-K · filed 2013-08-01 | $2.00M derived: sum of 3 quarters · filed 2013-10-31 | $2.00M derived: sum of 4 quarters · filed 2013-10-31 | |
| 2013-03-31 | $1.00M 6-K · filed 2013-05-02 | $2.00M derived: sum of 2 quarters · filed 2013-10-31 | $2.00M derived: sum of 3 quarters · filed 2013-10-31 | $1.00M derived: sum of 4 quarters · filed 2013-10-31 | |
| 2012-12-31 | $4.00M 20-F · filed 2014-02-10 | $1.00M derived: 6-K 12 month − 6-K 9 month · filed 2013-10-31 | $1.00M derived: sum of 2 quarters · filed 2013-10-31 | $0.00 derived: sum of 3 quarters · filed 2013-10-31 | $4.00M 6-K · filed 2013-10-31 |
| 2012-09-30 | $0.00 derived: 6-K 9 month − 6-K 6 month · filed 2012-11-01 | -$1.00M derived: sum of 2 quarters · filed 2012-11-01 | $3.00M 6-K · filed 2012-11-01 | $3.00M derived: sum of 4 quarters · filed 2012-11-01 | |
| 2012-06-30 | -$1.00M derived: 6-K 6 month − 6-K 3 month · filed 2012-08-02 | $3.00M 6-K · filed 2012-08-02 | $3.00M derived: sum of 3 quarters · filed 2012-11-01 | ||
| 2012-03-31 | $4.00M 6-K · filed 2012-05-09 | $4.00M derived: sum of 2 quarters · filed 2012-11-01 | |||
| 2011-12-31 | $22.00M 20-F · filed 2013-02-12 | $0.00 derived: 6-K 12 month − 6-K 9 month · filed 2012-11-01 | $22.00M 6-K · filed 2012-11-01 | ||
| 2011-09-30 | $22.00M 6-K · filed 2011-11-02 | ||||
| 2011-06-30 | $18.00M 6-K · filed 2011-07-28 | ||||
| 2011-03-31 | $11.00M 6-K · filed 2011-05-11 | ||||
| 2010-12-31 | $7.00M 20-F · filed 2012-02-17 | $7.00M 6-K · filed 2011-11-02 | |||
| 2010-03-31 | $7.00M 6-K · filed 2011-05-11 | ||||
| 2009-12-31 | -$2.00M 20-F · filed 2011-02-15 |